Attaching importance to the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia

Schizophr Res. 2022 May:243:462. doi: 10.1016/j.schres.2022.03.002. Epub 2022 Mar 23.

Authors

Chao-Hsiun Tang¹, Darmendra Ramcharran², Hong Qiu², Kuo-Hsuan Chung³

Affiliations

¹ School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan.
² Janssen Global Research & Development Epidemiology, Titusville, NJ, USA.
³ Department of Psychiatry and Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: [email protected].

PMID: 35337718
DOI: 10.1016/j.schres.2022.03.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antipsychotic Agents* / adverse effects
Cardiovascular Diseases* / chemically induced
Cause of Death
Death, Sudden / epidemiology
Death, Sudden / etiology
Death, Sudden, Cardiac / etiology
Humans
Risk Factors
Schizophrenia*

Substances

Antipsychotic Agents